alphaveAARTIPHARM₹829.05

Aarti Pharmalabs Ltd.

₹ CrorePeersAARTIDRUGS ADVENZYMES AGARWALEYE AKUMS ALIVUS APLLTD CORONA HCGMcap ₹7,516 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,014.7	1,104.1	1,335.9	1,335.9
+ Capital Work-in-Progress	78.5	306.6	305.2	305.2
+ Investment Property	0.0	—	65.5	65.5
+ Goodwill	1.8	1.8	0.0	0.0
+ Other Intangibles	16.9	30.7	36.0	36.0
+ Intangibles under Development	58.4	67.8	87.9	87.9
+ Investments (Equity Method)	36.8	—	—	—
+ Non-current Investments	0.0	29.2	193.8	193.8
+ Long-term Loans	5.9	7.3	7.8	7.8
+ Other Non-current Financial Assets	11.3	14.0	35.4	35.4
Non-current Financial Assets	17.2	50.6	237.1	237.1
+ Other Non-current Assets	12.3	22.7	16.8	16.8
Total Non-current Assets	1,236.5	1,584.2	2,084.4	2,084.4
Current Assets
+ Inventories	642.9	587.6	640.3	640.3
+ Current Investments	70.4	47.6	0.0	0.0
+ Trade Receivables	519.3	575.4	583.3	583.3
+ Cash & Cash Equivalents	23.6	6.7	8.5	8.5
+ Other Bank Balances	0.4	1.9	1.1	1.1
+ Short-term Loans	1.3	1.0	0.5	0.5
+ Other Current Financial Assets	6.3	5.1	153.6	153.6
Current Financial Assets	621.3	637.8	747.0	747.0
+ Other Current Assets	78.0	96.8	—	—
Total Current Assets	1,345.6	1,322.2	1,397.3	1,397.3
Total Assets	2,582.1	2,906.4	3,481.7	3,481.7
Equity
+ Equity Share Capital	45.3	45.3	45.3	45.3
+ Other Equity / Reserves	1,711.7	1,944.6	2,079.3	2,079.3
Equity — Owners of Parent	1,757.0	1,989.9	2,124.6	2,124.6
Total Equity	1,757.0	1,989.9	2,124.6	2,124.6
Liabilities
+ Borrowings — Non-current	0.0	103.6	185.8	185.8
+ Other Non-current Financial Liab	16.7	19.4	91.5	91.5
Non-current Financial Liabilities	16.7	122.9	277.3	277.3
+ Provisions — Non-current	6.1	8.1	7.9	7.9
+ Deferred Tax Liabilities	107.9	128.4	134.3	134.3
Non-current Liabilities	130.7	259.4	419.5	419.5
+ Borrowings — Current	264.1	292.8	499.8	499.8
+ Trade Payables	378.3	277.8	334.5	334.5
+ Other Current Financial Liab	34.7	56.4	81.7	81.7
Current Financial Liabilities	677.1	627.1	916.0	916.0
+ Provisions — Current	6.3	11.7	11.2	11.2
+ Current Tax Liabilities	0.0	1.1	—	—
+ Other Current Liabilities	11.0	17.1	10.3	10.3
Current Liabilities	694.4	657.0	937.6	937.6
Total Liabilities	825.1	916.5	1,357.1	1,357.1
Total Equity & Liabilities	2,582.1	2,906.4	3,481.7	3,481.7
Assets — additional as-filed lines
+ Current Tax Assets	3.4	—	9.9	9.9
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	11.5	1.2	1.2
+ Dues to Other Creditors — Current	—	266.3	333.4	333.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.